# ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors

> **NCT03497624** · — · COMPLETED · sponsor: **Addario Lung Cancer Medical Institute** · enrollment: 5 (actual)

## Conditions studied

- ROS1-fusion Positive Tumor

## Interventions

- **OTHER:** Biospecimens collection

## Key facts

- **NCT ID:** NCT03497624
- **Lead sponsor:** Addario Lung Cancer Medical Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2020-09-04
- **Final completion:** 2020-09-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497624, "ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03497624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*